Morphological and functional investigations of neuroendocrine tumors of the pancreas

被引:21
作者
Pereira, PL [1 ]
Wiskirchen, J [1 ]
机构
[1] Univ Tubingen, Dept Diagnost Radiol, D-372076 Tubingen, Germany
关键词
neuroendocrine tumors; pancreas; neoplasms; insulinoma; gastrinoma;
D O I
10.1007/s00330-003-1879-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Neuroendocrine tumors of the pancreas are rare neoplasms arising predominantly from the pancreatic islets of Langerhans and are thus known as islet cell tumors. More than the half of all neuroendocrine tumors are called functioning islet cell tumors because they secrete one or more biologically active peptides that may produce clinical symptoms. Clinical diagnosis of non-functioning, i.e., biologically inactive, tumors is often delayed and patients tend to present with advanced tumors (size greater than 5 cm) that are easily localized by using conventional imaging modalities. On the other hand, symptoms of functioning islet cell tumors usually appear early in the clinical course, rendering the preoperative localization of these small hormone-producing tumors (size less than 2 cm) difficult with non-invasive methods. Since functioning islet cell tumors can often be cured by surgical resection, invasive procedures are warranted when necessary for localization diagnosis. Failure to search for, detect, and resect these small tumors will invariably result in persistent symptoms. Regarding the unsatisfactory results of morphological imaging methods, functional studies, especially arterial stimulation with hepatic venous samplings, may provide a preoperative regionalization of the pancreatic adenoma, regardless of its size.
引用
收藏
页码:2133 / 2146
页数:14
相关论文
共 50 条
  • [31] Neuroendocrine tumors of the gastrointestinal tract and pancreas: Is it also a challenge for pediatricians?
    Stawarski, Andrzej
    Maleika, Pawel
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (02): : 265 - 270
  • [32] Primary hyperparathyroidism, adrenal tumors and neuroendocrine tumors of the pancreas -: clinical diagnosis and imaging requirements
    Auernhammer, CJ
    Engelhardt, D
    Göke, B
    RADIOLOGE, 2003, 43 (04): : 265 - +
  • [33] Neuroendocrine Tumors of the Pancreas: Current Concepts and Controversies
    Michelle D. Reid
    Serdar Balci
    Burcu Saka
    N. Volkan Adsay
    Endocrine Pathology, 2014, 25 : 65 - 79
  • [34] Neuroendocrine tumors of the pancreas - Benefits of new technologies
    Van Nieuwenhove, Y
    Vandaele, S
    de Beeck, BO
    Delvaux, G
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2003, 17 (10): : 1658 - 1662
  • [35] Hormone-inactive neuroendocrine tumors of the pancreas
    Schwab, M
    Knoll, MR
    Jentschura, D
    Hagmuller, E
    CHIRURG, 1997, 68 (07): : 705 - 709
  • [36] Neuroendocrine Tumors of the Pancreas: What's New
    Dimou, Anastasios T.
    Syrigos, Konstantinos N.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2010, 11 (02): : 135 - 138
  • [37] Advances in Management of Nonfunctional Pancreas Neuroendocrine Tumors
    Acher, Alexandra W.
    Hallet, Julie
    SURGICAL CLINICS OF NORTH AMERICA, 2024, 104 (05) : 1095 - 1111
  • [38] Neuroendocrine tumors of the pancreas: benefits of new technologies
    A. Rosiere
    S. Mulier
    L. Michel
    J. E. Donckier
    Surgical Endoscopy And Other Interventional Techniques, 2005, 19 : 1004 - 1005
  • [39] Hereditary neuroendocrine tumors of the gastroenteropancreatic system
    Anlauf, Martin
    Garbrecht, Nele
    Bauersfeld, Juliane
    Schmitt, Anja
    Henopp, Tobias
    Komminoth, Paul
    Heitz, Philipp U.
    Perren, Aurel
    Kloeppel, Guenter
    VIRCHOWS ARCHIV, 2007, 451 : S29 - S38
  • [40] Computed tomography and magnetic resonance imaging features of lipid-rich neuroendocrine tumors of the pancreas
    Fukukura, Yoshihiko
    Shindo, Toshikazu
    Higashi, Michiyo
    Takumi, Koji
    Umanodan, Tomokazu
    Yoneyama, Tomohide
    Yoshiura, Takashi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (34) : 10008 - 10017